Berger Financial Group, Inc
Source: SEC Form 13F · as of Mar 2026Berger Financial Group, Inc holds 16 biotech & pharma companies tracked by BioSniper, totaling $45.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$45.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 40,263 | $9.8M |
| GILDGILEAD SCIENCES, INC. | 47,146 | $6.6M |
| ABTABBOTT LABORATORIES | 61,615 | $6.3M |
| LLYELI LILLY & Co | 6,540 | $6.0M |
| CORCencora Inc. | 18,525 | $5.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 11,694 | $3.2M |
| ABBVAbbVie Inc. | 14,227 | $3.1M |
| AMGNAMGEN INC | 3,676 | $1.3M |
| MRKMerck & Co., Inc. | 8,427 | $1.0M |
| TECHBIO-TECHNE Corp | 14,785 | $773K |
| PMPhilip Morris International Inc | 4,512 | $746K |
| MCKMcKesson Corporation | 494 | $427K |
| PFEPFIZER INC | 10,548 | $296K |
| BMYBRISTOL MYERS SQUIBB CO | 4,029 | $244K |
| REGNREGENERON PHARMACEUTICALS, INC. | 300 | $232K |
| LXRXLEXICON PHARMACEUTICALS, INC. | 10,000 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.